Resultados Health Research 2022

<@liferay.language key='wos-mostrar-info' /> <@liferay.language key='wos-ocultar-info' />

Caixaresearch Health 2022 information

Total Budget

23.148.611,88 €

Number of projects presented

547

Number of projects evaluated

546

Number of projects preselected

80

Number of projects selected

33

Success rate

6,04 %

Table 1: General information of CaixaResearch Health Call 2022.

Figure 1: Budget distribution by territory

Figure 1: Budget distribution by territory

Thematic Area

Proj. Evaluated

Proj. Preselected (peer review)

Proj. Selected (expert panel)

Cardiovascular and metabolic diseases

63

16

25,4 %

5

7,9 %

Neuroscience

163

16

9,8 %

8

4,9 %

Infectious diseases

72

16

22,2 %

8

11,1 %

Oncology

111

16

14,4 %

6

5,4 %

Enabling technologies

137

16

11,7 %

6

4,4 %

 

546

80

14,7 %

33

6,0 %

Table 2: % of the preselected and selected projects compared to the submitted projects in each thematic area.

Thematic area

Proj. Evaluated

Proj. Preselected

Proj. Selected

Cardiovascular and metabolic diseases

Individual

22

5

1

Research Consortium

41

11

4

Total

63

16

5

Neuroscience

Individual

70

5

4

Research Consortium

93

11

4

Total

163

16

8

Infectious disease

Individual

33

7

7

Research Consortium

39

9

1

Total

72

16

8

Oncology

Individual

52

5

3

Research Consortium

59

11

3

Total

111

16

6

Enabling technologies

Individual

34

1

1

Research Consortium

103

15

5

Total

137

16

6

 

 

549

80

33

Table 3: Number of Individual and Research Consortium projects compared to the total number of projects of each thematic area.

Resultados Health Research 2021

<@liferay.language key='wos-mostrar-info' /> <@liferay.language key='wos-ocultar-info' />

Health Research 2021 Call for Proposals - information

HR21 Budget

22.115.490,50 €

Number of projects presented

644

Number of projects evaluated

644

Number of projects preselected

70

Number of projects selected

30

Success rate

4,66 %

Table: General information of Health Research 2021 Call for Proposals.

Resultados Health Research 2020

<@liferay.language key='wos-mostrar-info' /> <@liferay.language key='wos-ocultar-info' />

Health Research 2020 Call for Proposals - information

HR20 Budget

15.200.128 €

Number of projects presented

602

Number of projects evaluated

600

Number of projects preselected

62

Number of projects selected

21

Success rate

3,50 %

Table: General information of Health Research 2020 Call for Proposals.

Resultados Health Research 2019

<@liferay.language key='wos-mostrar-info' /> <@liferay.language key='wos-ocultar-info' />

Health Research 2019 Call for Proposals - information

HR18 Budget

15.376.337 €

Number of projects presented

632

Number of projects evaluated

629

Number of projects preselected

75

Number of projects selected

22

Success rate

3,50 %

Table: General information of Health Research 2019 Call for Proposals.

Resultados Health Research 2018

<@liferay.language key='wos-mostrar-info' /> <@liferay.language key='wos-ocultar-info' />

Health Research 2018 Call for Proposals - information

HR17 Budget

12.000.000 €

Number of projects presented

785

Number of projects evaluated

785

Number of projects preselected

77

Number of projects selected

20

Table: General information of Health Research 2018 Call for Proposals.

Projetos selecionados Health Research 2022

<@liferay.language key='wos-mostrar-info' /> <@liferay.language key='wos-ocultar-info' />

Code

Project Title

Project Leader

Host Organization

Partner Organizations

Thematic Area

Category

Budget (€)

HR22-00073

R-loop-mediated genome instability factors in cancer

Andrés Aguilera

Universidad de Sevilla

N/A

Oncology

Individual

500,000

HR22-00100

Using small-molecule inhibitors to explore the unique properties of the bacterial K+ machinery and its potential as an antibacterial target

João Morais Cabral

i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação

N/A

Infectious disease

Individual

498,999

HR22-00123

Moving from reactive to proactive strategies for the prevention of the next West Nile virus outbreak in Andalucía

Jordi Figuerola

Consejo Superior de Investigaciones Científicas (CSIC)

N/A

Infectious disease

Individual

499,909.28

HR22-00172

(Epi)Genomic and microenvironment interactions driving evolution in chronic lymphocytic leukemia. Targets for clinical intervention

Elías Campo

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)

Fundación Universidad de Oviedo; Centre de Regulació Genòmica (CRG)

Oncology

Research Consortium

999,806.30

HR22-00189

Neuromorphic devices for adaptive real-time neuromodulation in brain electrical stimulation therapies

Paulo Aguiar

i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação

Universidade do Porto; Consejo Superior de Investigaciones Científicas (CSIC); Centro Hospitalar Universitário do Porto, E.P.E.

Enabling Technologies

Research Consortium

965,888.78

HR22-00221

Antibody-mediated NMDA receptor encephalitis: symptoms, biomarkers, and mechanisms of the prolonged recovery stage

Josep Dalmau

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)

Fundació Privada per a la Recerca i la Docència Sant Joan de Déu

Neuroscience

Research Consortium

972,352.39

HR22-00253

Harnessing the adaptive immune response in vascular pathologies: towards the identification of new therapeutic avenues

Almudena R. Ramiro

Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC

Fundación Instituto de Investigación Sanitaria of the Fundación Jiménez Díaz

Cardiovascular and associated metabolic diseases

Research Consortium

750,042.40

HR22-00316

Understanding and promoting the growth and regenerative functions of blood vessels in heart disease

Rui Benedito

Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC

Centre de Regulació Genòmica (CRG); Fundació Institut de Recerca Contra la Leucèmia Josep Carreras; University Hospital RWTH Aachen

Cardiovascular and associated metabolic diseases

Research Consortium

999,948.04

HR22-00394

Epigenetic basis of gene-environment interactions underlying variation in Cognitive capabilities and their Decline with Age

Angel Barco

Consejo Superior de Investigaciones Científicas (CSIC)

N/A

Neuroscience

Individual

498,000

HR22-00395

Vascularized lymphoma on-chip: a multifaceted tool for translational research

Patricia Perez

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)

European Molecular Biology Laboratory Barcelona

Enabling Technologies

Research Consortium

499,871.26

HR22-00402

Potentiating cancer immunotherapy by inhibiting the NMD quality-control pathway guided by genetic markers

Fran Supek

Fundació Institut de Recerca Biomèdica (IRB Barcelona)

Universitat Pompeu Fabra (UPF)

Oncology

Research Consortium

998,900.50

HR22-00405

Accelerated evolution of high-weight protein complexes for precision antimicrobials

Alfonso Jaramillo

Consejo Superior de Investigaciones Científicas (CSIC)

N/A

Enabling Technologies

Individual

482,730

HR22-00447

Metabolic communication between immune cells orchestrates the response to pathogens

Nuria Martínez

Consejo Superior de Investigaciones Científicas (CSIC)

N/A

Infectious disease

Individual

496,685.86

HR22-00529

Novel mutational mechanisms of somatic retrotransposition in the context of the 3D cancer genome

Jose Tubio

Universidad de Santiago de Compostela

N/A

Oncology

Individual

495,476.89

HR22-00533

A DIRect QuanTitative assessment of Heart disease with magnetic resonance imaging

Teresa Matias

Centro De Ciências Do Mar Do Algarve

Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC; Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento; Universidad de Valladolid

Cardiovascular and associated metabolic diseases

Research Consortium

998,472.90

HR22-00551

Endothelial Cells as rheostats for Age-Related Diseases

Claudio Franco

Instituto de Medicina Molecular

N/A

Cardiovascular and associated metabolic diseases

Individual

499,818.88

HR22-00569

NRF2 as a novel therapeutic target in early and intermediate age-related macular degeneration

Miguel Seabra

Universidade Nova de Lisboa

Centro Investigation Biomedica en Redes Neurodegenerativas - CIBERNED

Neuroscience

Research Consortium

985,013

HR22-00602

New nanotechnological therapy for Parkinson's disease: nose to brain delivery of GBA-polymer nanoconjugates

Marta Martínez

Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR)

Universitat Autònoma de Barcelona (UAB); Centro de Investigación Príncipe Felipe

Neuroscience

Research Consortium

599,723.00

HR22-00668

Uncovering the Differentiation Determinants and Dynamics of Congenital Susceptibility to Infections

Esteban Ballestar

Fundació Institut de Recerca Contra la Leucèmia Josep Carreras

Fundació Josep Carreras contra la Leucemia

Infectious disease

Individual

477,722.19

HR22-00681

Epigenetic regulation of host immunity and neurological long-term consequences of SARS-CoV-2 infection

Christian Brander

Institut de Recerca de la Sida "la Caixa" - IRSICAIXA

Centre de Regulació Genòmica (CRG); Fundació FLS de lluita contra la sida, les malalties infeccioses i la promoció de la salut i la ciencia; Institut De Recerca I Tecnología Agroalimentaria

Infectious disease

Research Consortium

999,580

HR22-00702

Multifunctional nano-immunotherapy against breast brain metastases

Helena Florindo

FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento

Tel Aviv University

Enabling Technologies

Research Consortium

853,405.70

HR22-00722

The BioPlaTTAR Platform for the Tailored and Rapid Development of Antiviral Biopharmaceuticals

Cláudio Manuel Soares

Universidade Nova de Lisboa

Instituto de Medicina Molecular; Fundação Calouste Gulbenkian; Consejo Superior de Investigaciones Científicas (CSIC)

Enabling Technologies

Research Consortium

1,000,000

HR22-00732

Somatic mutations and clonal hematopoiesis as predictors and drivers of heart failure progression

José Javier Fuster

Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC

Fundació Institut de Recerca Contra la Leucèmia Josep Carreras; Fundació Institut d’Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP); Fundació Josep Carreras contra la Leucemia; Fundació Institut de Recerca Biomèdica (IRB Barcelona); Fundación para la Formación e Investigación Sanitarias de la Región de Murcia

Cardiovascular and associated metabolic diseases

Research Consortium

998,043.28

HR22-00741

Harnessing germinal centre regulation for improved vaccines

Luis Graca

Instituto de Medicina Molecular

Cultivamos Cultura

Infectious disease

Individual

499,952

HR22-00754

Role of diet-derived retinoids in CD8αα intraepithelial lymphocytes and intestinal defence at early-life

Manuela Ferreira

Universidade de Coimbra

N/A

Infectious disease

Individual

408,077.71

HR22-00776

Role of cellular senescence during breast cancer progression and treatment

Joaquín Arribas

Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM)

N/A

Oncology

Individual

500,000

HR22-00778

Circuit mechanisms for associating high-order cortical activity with expected sensory representations in health and desease

Leopoldo Petreanu

Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud

N/A

Neuroscience

Individual

499,976.40

HR22-00799

T cell acute lymphoblastic leukemia: Origin & Relapse

Vera Sofia Correia Martins

Fundação Calouste Gulbenkian

Universität Ulm

Oncology

Research Consortium

681,932.54

HR22-00813

Highly efficient technology for clean and safe air: development of advanced air purifiers to inactivate pathogens in aerosols

Miguel A. Bañares

Consejo Superior de Investigaciones Científicas (CSIC)

Fundación para la Investigación Biomédica del Hospital Universitario La Paz; Hospital Universitario Severo Ochoa

Enabling Technologies

Research Consortium

997,000

HR22-00854

The dynamic membrane traffic at the neuronal synapse: Endosomal sub-compartments in health and disease

Ira Milosevic

Universidade de Coimbra

N/A

Neuroscience

Individual

492,837.85

HR22-00879

Whole-systems Analysis of the Microbiome-Metabolome Crosstalk for Biomarker Discovery and Therapy of Respiratory Fungal Diseases

Cristina Cunha

Universidade do Minho

N/A

Infectious disease

Individual

499,646.79

HR22-00890

Modulating nucleolar activity and stress responses as a therapeutic strategy in ALS

Oscar Fernandez-Capetillo

Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III

N/A

Neuroscience

Individual

498,850

Projetos selecionados Health Research 2021

<@liferay.language key='wos-mostrar-info' /> <@liferay.language key='wos-ocultar-info' />

Code

Project Title

Project Leader

Host Organization

Partner Organizations

Thematic Area

Category

Budget (€)

HR21-00046

Decoding the paracrine control of metabolic fitness by endothelial nutrient signaling

Alejo Efeyan

Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III

Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)

Cardiovascular and associated metabolic diseases

Research Consortium

992.580,60

HR21-00386

High precision cardioprotective therapy: a photoswitchable approach to reduce the extension of myocardial infarction

Amadeu Llebaria

Consejo Superior de Investigaciones Científicas (CSIC)

Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR) - Purdue University, West Lafayette, IN - GICOR

Cardiovascular and associated metabolic diseases

Research Consortium

999.779,50

HR21-00430

Phospholipid biosynthesis and transport between endoplasmic reticulum and mitochondria: understanding their essential role in liver disorders

Antonio Zorzano

Fundació Institut de Recerca Biomèdica (IRB Barcelona)

Universitat de Barcelona - Fundació Institut d'Investigació Sanitària Pere Virgili

Cardiovascular and associated metabolic diseases

Research Consortium

997.014

HR21-00233

Loss of Triadin impairs cardiac proteostasis disclosing pathophysiological complexity in Catecholaminergic Polymorphic Ventricular Tachycardia Type 5

Silvia Giuliana Priori

Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC

N/A

Cardiovascular and associated metabolic diseases

Individual

496.100

HR21-00793

RIPK3 biology and targeting in metabolic liver disease

Cecilia Rodrigues

FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento

N/A

Cardiovascular and associated metabolic diseases

Individual

320.000,07

HR21-00375

Massively parallel mutagenesis to understand, predict and prevent amyloid nucleation in neurodegenerative diseases

Ben Lehner

Centre de Regulació Genòmica (CRG)

Institut de Bioenginyeria de Catalunya

Enabling technologies

Research Consortium

994.048,90

HR21-00925

Development of enabling technologies for T-cell immunotherapy of solid tumors

Sonia Guedán

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)

Asociación Centro de Investigación Cooperativa en Biociencias (CIC bioGUNE) - Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO)

Enabling technologies

Research Consortium

963.488

HR21-00410

Graphene aptasensor bioelectronics: a neural interface for neurotransmission probing in neurological disorders

Pedro Alpuim

Laboratorio Iberico Internacional de Nanotecnologia

Universidade do Minho - Consejo Superior de Investigaciones Científicas (CSIC)

Enabling technologies

Research Consortium

997.692,19

HR21-00208

Enzyme propelled nanobots as efficient nanotech platform for bladder cancer therapy

Samuel Sánchez

Institut de Bioenginyeria de Catalunya

Asociación Centro de Investigación Cooperativa en Biomateriales - Universitat Autònoma de Barcelona (UAB) - Fundació Clínic per a la Recerca Biomèdica -Fundacio Catalunya-La Pedrera Fundacio Especial - Universitat de Barcelona - Fundació Bosch i Gimpera

Enabling Technologies

Research Consortium

997.946,50

HR21-00415

A multidisciplinary approach to understand host and pathogen interactions to develop new strategies to target tuberculosis

Margarida Saraiva

i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação

Consejo Superior de Investigaciones Científicas (CSIC) - Francis Crick Institute

Infectious diseases

Research Consortium

998.404

HR21-00848

Whole-organism vaccines against P. falciparum and P. vivax malaria with enhanced efficacy and scope

Miguel Prudêncio

Instituto de Medicina Molecular

Leiden University Medical Centre - US Naval Medical Research Unit 6

Infectious diseases

Research Consortium

997.453,50

HR21-01020

Neuron-astrocyte signaling in depression: learning from astrocytes how to effectively treat depression

João Filipe Oliveira

Universidade do Minho

N/A

Neuroscience

Individual

499.478,45

HR21-00171

Novel organ-on-a-chip technology to study extracellular vesicles-mediated cryptic infections in Plasmodium vivax malaria

Hernando A. del Portillo

Institut de Salut Global de Barcelona (ISGlobal)

i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação - Universitat de Barcelona - Mahidol University

Infectious diseases

Research Consortium

996.930,57

HR21-00368

Molecular dissection of TNF-mediated pathogenic macrophage necrosis in tuberculosis

Francisco Jose Roca Soler

Universidad de Murcia

N/A

Infectious diseases

Individual

460.252,80

HR21-00737

Acquisition of antifungal resistance in pathogenic Candida spp.: evolutionary paths, fitness trade-offs, and interplay with the immune system

Toni Gabaldón

Fundació Institut de Recerca Biomèdica (IRB Barcelona)

N/A

Infectious diseases

Individual

499.244

HR21-00622

In vivo reprogramming to rescue alterations in Huntington’s disease

Josep M. Canals

Universitat de Barcelona - Fundació Bosch i Gimpera

Lund University - Cardiff University - Institute of Molecular Biotechnology (IMBA)- European Huntington's Disease Network

Neuroscience

Research Consortium

994.890

HR21-00259

From GFAP mutations in astrocytes to neurodegeneration: exploring a lipid-protein oxidation pathway

Dolores Pérez-Sala

Consejo Superior de Investigaciones Científicas (CSIC)

Brain Center, University Medical Center Utrecht -University of Copenhagen - University of Gothenburg -Institut De Recerca Biomedica De Lleida. Fundació Dr. Pifarre

Neuroscience

Research Consortium

1.000.000

HR21-00824

A strategy to guide and promote spinal and visual axons regeneration after injury

Eloísa Herrera

Consejo Superior de Investigaciones Científicas (CSIC)

N/A

Neuroscience

Individual

495.500

HR21-01136

Deep learning of a hippocampal memory code in health and disease

Liset Menéndez de la Prida

Consejo Superior de Investigaciones Científicas (CSIC)

N/A

Neuroscience

Individual

491.700

HR21-01208

RBM10, a novel splicing regulator and tumor suppressor: from mechanisms to therapies

Juan Valcárcel

Centre de Regulació Genòmica (CRG)

Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III

Oncology

Research Consortium

816.239,46

HR21-00176

Understanding lncRNAs in replicative stress and colorectal cancer: from cancer biology to single-molecules

Maite Huarte

Fundación para la Investigación Médica Aplicada (FIMA/CIMA)

Consejo Superior de Investigaciones Científicas (CSIC) - Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III

Oncology

Research Consortium

995.200

HR21-00761

IL7R in lung cancer development, metastasis and resistance to immune checkpoint inhibitor therapy

João Barata

Instituto de Medicina Molecular

Fundación para la Investigación Biomédica del Hospital Universitario 12 de Octubre - Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III

Oncology

HR Consortium

999.962

HR21-00083

Interleukin-8 and neutrophil extracelular traps as actionable hurdles for cancer immunotherapy

Ignacio Melero

Fundación para la Investigación Médica Aplicada (FIMA/CIMA)

N/A

Oncology

Individual

498.850

HR21-00020

Cracking the cancer tubulin code for precision oncology

Helder Maiato

i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação

N/A

Oncology

Individual

499.983

Projetos premiados em colaboração com a Fundação Luzon

HR21-00931

Targeting TDP-43 with protein kinase inhibitors: a effective and measurable therapy for ALS

Ana Martinez

Consejo Superior de Investigaciones Científicas (CSIC)

FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento -Universidad Complutense de Madrid

Neuroscience

Research Consortium

500.000

Projetos premiados em colaboração com a Fundação para a Ciência e a Tecnologia, I.P. no âmbito da "Iniciativa Ibérica de Investigação e Inovação Biomédica, i4b"

HR21-01212

Decoding the non-code of beta-cells cis-regulation

Jose Bessa

i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação

N/A

Cardiovascular and associated metabolic diseases

Individual

499.355

HR21-00605

Protecting the brain from metastatic breast cancer

Miguel Castanho

Instituto de Medicina Molecular

Asociación Instituto Biodonostia - FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento - Asociación Centro de Investigación Cooperativa en Biomateriales

Enabling Technologies

Research Consortium

632.841

HR21-00533

A flexible platform for generating synthetic virus to control infectious diseases

Joana Azeredo

Universidade do Minho

N/A

Infectious diseases

Individual

492.460,48

HR21-01077

Regulation of prefrontal cortical synaptic function and behavior by chronic stress-induced microRNA-186-5p

Paulo Pinheiro

Centro de Neurociências e Biologia Celular

N/A

Neuroscience

Individual

492.304,48

HR21-00077

Regulatory RNA–protein interactions at telomeres in healthy cells and during malignant transformation

Claus Maria Azzalin

Instituto de Medicina Molecular

N/A

Oncology

Individual

495.792

Projetos selecionados Health Research 2020

<@liferay.language key='wos-mostrar-info' /> <@liferay.language key='wos-ocultar-info' />

Code

Project Title

Project Leader

Host Institution

Partner Institutions

Thematic Area

Category

Budget (€)

HR20-00493

Function of a novel program of islet microexons in beta cell development, insulin secretion and diabetes

Manuel Irimia

Centre de Regulació Genòmica (CRG)

N/A

Cardiovascular and metabolic diseases

Individual

499.592

HR20-00075

Flow-driven inflammation and arterial wall remodeling in atherosclerosis: mechanisms and therapeutic potential

Miguel Ángel del Pozo

Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC

Yale University, New Haven, CT, Aarhus University, Asociación Centro de Investigación Cooperativa en Biomateriales

Cardiovascular and metabolic diseases

Research Consortium

999.987

HR20-00322

RNA mis-splicing in hypertrophic cardiomyopathy: opportunities for diagnosis and therapy

Maria Carmo-Fonseca

Instituto de Medicina Molecular

Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento, Associação para Investigação e Desenvolvimento da Faculdade de Medicina

Cardiovascular and metabolic diseases

Research Consortium

986.964

HR20-00051

Succinate/SUCNR1 axis: a novel target for anti-obesity therapies

Sonia Fernandez

Fundació Institut d'Investigació Sanitària Pere Virgili

Universidad de Santiago de Compostela, Institut D'Investigació Biomèdica De Girona (IDIBGI)

Cardiovascular and metabolic diseases

Research Consortium

998.902

HR20-00369

Enabling technologies to map nuclear mechanosensing: from organoids to tumors

Xavier Trepat

Institut de Bioenginyeria de Catalunya

Netherlands Cancer Institute

Enabling technologies

Research Consortium

984.630

HR20-00800

Deep Learning to Dissect the Interaction between Leukemic Cells and the Ageing Niche

M. Carolina Florian

Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)

Universität Ulm

Enabling technologies

Research Consortium

817.045

HR20-00637

BioPrinted hydROgel MicrofluIdicS to mimic patient-specific tumor mEtastatic microenvironment

Elena Martinez

Institut de Bioenginyeria de Catalunya

Laboratorio Ibérico Internacional de Nanotecnologia, Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO)

Enabling technologies

Research Consortium

981.675

HR20-00428

Heterogenous protein acylation and cancer

Gemma Triola

Consejo Superior de Investigaciones Científicas (CSIC)

N/A

Enabling technologies

Individual

341.242

HR20-00218

Enhancing Tissue-Specific Immune Microenvironments for the Cure of HIV

María José Buzón

Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR)

Consejo Superior de Investigaciones Científicas (CSIC), Institut de Recerca de la Sida "la Caixa" - IRSICAIXA

Infectious diseases

Research Consortium

699.134

HR20-00361

Mechanism and function of epitranscriptomic poly(A) tail modifications in African trypanosomes

Luisa Figueiredo

Instituto de Medicina Molecular Joao Lobo Antunes

N/A

Infectious diseases

Individual

499.400

HR20-00635

Coping with unpredictability: regulatory plasticity as an adaptation strategy in the human malaria parasite

Elena Gomez-Díaz

Consejo Superior de Investigaciones Científicas (CSIC)

University of Glasgow, University of Sciences, Techniques and Technologies of Bamako (USTTB), Malaria Rsearch and Training Center

Infectious diseases

Research Consortium

999.548

HR20-00584

Discovery of new antiparasitic drug candidates and innovative modes of actions from Microbial Natural Products

Olga Genilloud

Fund. Centro de Excelencia en Inv. de Medicamentos Innovadores en Andalucia

Drugs for Neglected Diseases Initiative (DNDi), Institut Pasteur korea

Infectious diseases

Research Consortium

995.251

HR20-01000

Encoding reward and aversion in the mammalian brain: the overlooked role of endogenous opioids

Ana Joao Rodrigues

Universidade do Minho

N/A

Neuroscience

Individual

499.788

HR20-00083

Restoration of sensory circuits based on glia-to-neuron reprogramming

Guillermina López-Bendito

Consejo Superior de Investigaciones Científicas (CSIC)

N/A

Neuroscience

Individual

499.000

HR20-00081

Amino acid transporter structure to target glutamate transmission in neuro diseases

Manuel Palacin

Fundació Institut de Recerca Biomèdica (IRB Barcelona)

Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III

Neuroscience

Research Consortium

428.500

HR20-00896

Mitochondrial transcription as a trigger for neurodegenation

Albert Quintana

Universitat Autònoma de Barcelona (UAB)

N/A

Neuroscience

Individual

500.000

HR20-00714

A cortical pathogenesis of Parkinson's disease

Guglielmo Foffani

Fundación de Investigación HM Hospitales

N/A

Neuroscience

Individual

500.000

HR20-00465

Immunomodulatory drivers in melanoma progression and therapy response

Marisol Soengas

Fund. del Sector Público Estatal Centro Nacional de Inv. Oncológicas Carlos III

N/A

Oncology

Individual

481.597

HR20-00164

A new functional paradigm for RhoA gene mutations in peripherial Tcell Lymphoma: Functional and Clinical implications

Xose R. Bustelo

Fundación de Investigación del Cancer

N/A

Oncology

Individual

498.300

HR20-00871

Gene Regulatory NETworks in NORmal and MALignant Hematopoiesis-Identification and Targeting (GR-NET NORMAL-HIT)

Felipe Prosper

Universidad de Navarra

Fundación para la Investigación Médica Aplicada (FIMA/CIMA), Fundación Miguel Servet - Navarrabiomed, University of Cambridge

Oncology

Research Consortium

999.410

HR20-00411

Virtual patient derived xenografts for tumor treatment

Luciano Di Croce

Centre de Regulació Genòmica (CRG)

Fundació Sant Joan de Déu

Oncology

Research Consortium

990.160

Proyectos galardonados en colaboración con la Fundación Luzón

HR20-01109

Brain Liquid Biopsy for Alzheimer disease and neurodegenerative disorders

Maite Mendioroz

Fundación Miguel Servet - Navarrabiomed

N/A

Neuroscience

Individual

482.847

Proyectos galardonados en colaboración con la Fundação para a Ciência e a Tecnologia, I.P. en el marco de la “Iniciativa Ibérica de Investigaçao e Inovaçao Biomédica, i4b"

HR20-00249

Diamond Photonics Platforms for Synaptic Connectivity Assessment in Healthy and Parkinson Disease Neuronal Models

Jana B. Nieder

Laboratorio Ibérico Internacional de Nanotecnologia

Universidade do Minho, Universidade de Aveiro

Enabling technologies

Research Consortium

999.981

HR20-00841

Unravelling pulmonary neuroimmune circuits during infection

Henrique Veiga-Fernandes

Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud

N/A

Infectious disease

Individual

499.950

HR20-00904

Potassium channel dysfunction in models of neurodevelopmental disorders

Ana Luisa Carvalho

Centro de Neurociências e Biologia Celular

IINS - Interdisciplinary Institute for Neuroscience, CNRS 5297, University of Bordeaux

Neuroscience

Research Consortium

782.000

Projetos selecionados Health Research 2019

<@liferay.language key='wos-mostrar-info' /> <@liferay.language key='wos-ocultar-info' />

Code

Project Title

Project Leader

Host Institution

Partner Institutions

Thematic Area

Category

Budget (€)

HR1818-00120

Mapping the pathogenesis of vascular malformations

Mariona Graupera

Institut d'Investigació Biomèdica de Bellvitge

Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.), Fundación Privada Hospital de la Santa Creu i Sant Pau, Fundació Sant Joan de Déu

Cardiovascular and metabolic diseases

Research Consortium

755.018

HR1818-00068

Nitric Oxide signaling and proteoglycans in Marfan syndrome’s aortopathy: mechanisms and new therapeutic targets

Juan Miguel Redondo Moya

Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)

Consejo Superior de Investigaciones Científicas

Cardiovascular and metabolic diseases

Research Consortium

500.000

HR1818-00304

Dysfunction of Ion Channel Complexes in Inheritable Cardiac Diseases

José Jalife

Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)

N/A

Cardiovascular and metabolic diseases

Individual

499.895

HR1818-00100

Hypothalamic control of gut function and microbiota composition: implications for energy balance regulation

Marc Claret Carles

Institut d'Investigacions Biomèdiques August Pi i Sunyer

Université catholique de Louvain (UCLouvain), Universidad de Santiago de Compostela

Cardiovascular and metabolic diseases

Research Consortium

972.183

HR1818-00359

Origin and functions of the tumor stroma in metastatic colorectal cancer

Eduard Batlle

Fundació Institut de Recerca Biomèdica (IRB Barcelona)

N/A

Oncology

Individual

499.997

HR1818-00069

Next-generation CAR-DOT cells for allogeneic adoptive cancer immunotherapy

Bruno Miguel de Carvalho Silva-Santos

Instituto de Medicina Molecular

Josep Carreras Leukemia Research Institute (JCLRI)

Oncology

Research Consortium

999.997

HR1818-00302

Post-transcriptional gene regulation reprogramming in obesity-driven liver cancer

Raúl Méndez

Fundació Institut de Recerca Biomèdica (IRB Barcelona)

N/A

Oncology

Individual

499.883

HR1818-00256

Defining The Role of Exosome-Secreted Micropeptides in Pancreatic Cancer

Maria Abad

Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO)

Fundación Centro Nacional de Investigaciones Oncológicas Carlos III, Champalimaud Foundation

Oncology

Research Consortium

694.600

HR1818-00023

Targeting Telomeres in Cancer

Maria A. Blasco

Fundación Centro Nacional de Investigaciones Oncológicas Carlos III

N/A

Oncology

Individual

489.100

HR1818-00589

Sensitizing pancreatic cancer to immunotherapy with multimodal precision nanomedicines

Maria Jesús Vicent Docón

Centro de Investigación Príncipe Felipe

Facultade de Farmacia da Universidade de Lisboa, Sackler Faculty of Medicine. Tel Aviv University

Enabling technologies

Research Consortium

985.042

HR1818-00501

Light-regulated drugs to restore sight

Pau Gorostiza Langa

Institut de Bioenginyeria de Catalunya

Universidad Miguel Hernández de Elche (UMH), Consejo Superior de Investigaciones Científicas, Barcelona Macula Foundation Research (BMF), Universidad de Alcalá (UAH)

Enabling technologies

Research Consortium

498.051

HR1818-00336

Community-Driven Big Data Intelligence to Fight Mosquito-Borne Disease

Frederic Bartumeus Ferré

Consejo Superior de Investigaciones Científicas

Universitat Pompeu Fabra, Max Planck Institute for Demographic Research (MPDIR), National Center of Epidemiology (CNE). CIBERESP/ISCIII., Centre for Ecological Research and Forestry Applications (CREAF), Agència de Salut Pública de Barcelona (ASPB),Agencia de Salut Pública de Catalunya (ASPCAT). Generalitat de Catalunya, Centro de Coordinación de Alertas y Emergencias Sanitarias (CCAES)

Enabling technologies

Research Consortium

999.920

HR1818-00313

Adaptive Retinal Implant Technology for Vision Restoration

Jose Antonio Garrido Ariza

Fundació Institut Català de Nanociència i Nanotecnologia

Institut de Física d'Altes Energies (IFAE), The Institute of Photonic Sciences (ICFO), Barraquer Foundation (BF), Institut de la Vision (Sorbonne Université)

Enabling technologies

Research Consortium

999.715

HR1818-00058

Bacterial lung chassis for treating human lung infectious diseases

Luis Serrano Pubul

Fundació Centre de Regulació Genòmica

Institut d'Investigacions Biomèdiques August Pi i Sunyer

Infectious diseases

Research Consortium

999.528

HR1818-00469

Locking cells against Ebola virus

Carmen Gil

Consejo Superior de Investigaciones Científicas

Instituto de Investigación Biomédica Hospital 12 de Octubre (Imas12), Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Bernhard Nocht Institute for Tropical Medicine

Infectious disease

Research Consortium

995.068

HR1818-00267

Dissecting the initial molecular events that trigger sexual conversion and transmission in malaria parasites

Alfred Cortés Closas

Barcelona Institute for Global Health (ISGlobal)

N/A

Infectious diseases

Individual

499.400

HR1818-00104

Enhancing Tissue Resident Immunity

Marc Veldhoen

Instituto de Medicina Molecular

N/A

Infectious diseases

Individual

497.158

HR1818-00155

Exosome targeting of the hypothalamus: a novel strategy for the treatment of obesity

Miguel Antonio López Pérez

Universidad de Santiago de Compostela

N/A

Neuroscience

Individual

448.300

HR1818-00026

DUbbing Language-therapy CINEma-based in Aphasia post-Stroke. A feasibility cross-over pilot-trial

Blanca Fuentes Gimeno

Hospital Universitario la Paz

Universidad Pontificia de Comillas, Afasia Activa

Neuroscience

Research Consortium

308.066

HR1818-00178

Dyslexia and the thalamus: Integrating anatomy and function in a mechanistic account of the reading brain

Manuel Francisco Carreiras Valiña

Asociacion Basque Center on Cognition, Brain and Language

N/A

Neuroscience

Individual

500.000

HR1818-00452

Modulation of Tau seeding and pathology in tauopathies by BBB-nanocarriers, epitope selective vaccination and ectoPrP Tau receptor bodies

José Antonio Del Río Fernández

Institut de Bioenginyeria de Catalunya

Institut d'Investigació Biomèdica de Bellvitge, Institute for Research in Biomedicine (IRB Barcelona), Universitat de Barcelona and Institute of Complex Systems (UBICS)

Neuroscience

Research Consortium

763.002

HR1818-00007

Dynamics of the neural, metabolomic and neuropsychological signatures underlying the adaptations for motherhood during pregnancy

Oscar Vilarroya Oliver

Universitat Autònoma de Barcelona

Fundació Institut Mar d'Investigacions Mèdiques, Instituto de Investigación Sanitaria Gregorio Marañón , University of Lleida-IRBLleida, Reproductive Medicine Service at Dexeus Women Health

Neuroscience

Research Consortium

972.414

Projetos premiados em colaboração com a Fundação Luzon

HR1818-000341

A potential metabolic-targeted therapeutic for Amyotrophic lateral sclerosis (ALS): Leptin

Carmen Maria Fernandez-Martos

Fundación Hospital Nacional de Parapléjicos

San Pablo University, King´s College London and Wicking Dementia Centre/University of Tasmania

Neuroscience

Research Consortium

499979

Projetos premiados em colaboração com a Fundação para a Ciência e a Tecnologia, I.P. no âmbito da "Iniciativa Ibérica de Investigação e Inovação Biomédica, i4b"

HR1818-00187

Targeting induced-senescent cells: a novel approach to promote spinal cord regeneration in mammals

Leonor Saúde

Instituto de Medicina Molecular

N/A

Neuroscience

Individual

444048

HR1818-00502

Metabolic Reprograming In Sepsis

Miguel Che Parreira Soares

Fundação Calouste Gulbenkian

Universitätsklinikum Jena, Center for Sepsis Control and Care, Thüringen (Germany)

Infectious disease

Research Consortium

500000

Projetos selecionados Health Research 2018

<@liferay.language key='wos-mostrar-info' /> <@liferay.language key='wos-ocultar-info' />

Code

Project Title

Project Leader

Host Institution

Partner Institutions

Thematic Area

Category

Budget (€)

HR17- 00016

Readying immune cells prior to disease-inducing encounters

Francisco Sánchez-Madrid

Centro Nacional de Investigaciones Cardiovasculares (CNIC)

N/A

Infectious disease

A

499.731

HR17- 00040

Understanding muscle regenerative decline with aging

Pura Muñoz-Cánoves

Universitat Pompeu Fabra (UPF)

N/A

Other biomedical areas

A

496.630

HR17- 00092

Metastasis Cell Fate Mapping

Roger Gomis Cabré

Institute for Research in Biomedicine (IRB)

N/A

Oncology

A

489.400

HR17- 00094

Eradicating prostate cancer metastasis before clinical manifestation

Arkaitz Carracedo

CIC bioGUNE

University of Cambridge (UK), Fundação Champalimaud (Lisboa), CIC biomaGUNE, Basurto Hospital

Oncology

A

499.915

HR17- 00149

A Translational Model of Antibody-mediated Synaptic Disease: Symptoms, Neuronal Circuits, and the Mechanisms of Memory Loss and Recovery

Josep Dalmau Obrador

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)

N/A

Neuroscience

A

498.718

HR17- 00199

Towards a universal therapeutic vaccine against chronic virus infections

Andreas Meyerhans

Universitat Pompeu Fabra (UPF)

IrsiCaixa

Infectious disease

A

484.316

HR17- 00221

Genomic and epigenomic drivers of disease evolution in chronic lymphocytic leukemia. Targets for clinical intervention

Elías Campo

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)

Universidad de Oviedo (UNIOVI), Barcelona Supercomputing Center (BSC)

Oncology

B

999.270

HR17- 00231

Regenerating photoreceptors in human retinal organoids to establish a treatment for Retinitis Pigmentosa

Maria Pia Cosma

Fundació Centre de Regulació Genòmica (CRG)

Institute for Bioengineering of Catalonia (IBEC), Instituto Barraquer

Neuroscience

A

499.519

HR17- 00232

Exploiting post-transcriptional regulation to uncover novel vulnerabilities of metastatic cells

Fátima Gebauer Hernández

Fundació Centre de Regulació Genòmica (CRG)

Centro Nacional de Investigaciones Oncológicas (CNIO)

Oncology

A

499.980

HR17- 00247

The antibody immune response during vascular remodeling

Almudena Rodríguez Ramiro

Centro Nacional de Investigaciones Cardiovasculares (CNIC)

Fundación Jimenez Diaz

Cardiovascular disease

A

499.963

HR17- 00264

Plasmodium Exploitation of Liver-specific Methionine Metabolism

Maria M. Mota

Instituto de Medicina Molecular (IMM), Lisboa

N/A

Infectious disease

A

499.950

HR17- 00267

Somatic Mutation-driven Clonal Hematopoiesis in Atherosclerosis - International Consortium

Valentí Fuster

Centro Nacional de Investigaciones Cardiovasculares (CNIC)

University of Virginia (UVA)

Cardiovascular disease

B

999.896

HR17- 00268

Therapeutic targeting of MBNL microRNAs as innovative treatments for myotonic dystrophy

Ruben Artero-Allepuz

Universitat de Valencia

University of Oxford (UK), Institute for Bioengineering of Catalonia (IBEC), Institut IMAGINE (France), Institute Biodonostia, ASEM & Myotonic Dystrophy Foundation

Other biomedical areas

B

997.024

HR17- 00323

Optical dissection of cortical circuits for sensory expectations

Leopoldo Petreanu

Fundação Champalimaud, Lisboa

N/A

Neuroscience

A

499.708

HR17- 00409

Fighting Zika virus with antiviral peptides and conjugates translocating blood-placental and blood-brain barriers

David Andreu Martínez

Universitat Pompeu Fabra (UPF)

Instituto de Medicina Molecular (IMM), Instituto de Bioquímica Médica Leopoldo de Meis

Infectious disease

B

777.250

HR17- 00513

Modulation of age-dependent neuromelanin accumulation as a novel therapeutic strategy for Parkinson’s disease and brain aging

Miquel Vila Bover

Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR)

N/A

Neuroscience

A

466.004

HR17- 00527

Therapeutic targeting of the neutrophil clock in cardiovascular disease

Andrés Hidalgo Alonso

Centro Nacional de Investigaciones Cardiovasculares (CNIC)

Universidad Complutense de Madrid (UCM), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)

Cardiovascular disease

A

499.998

HR17- 00539

Identifying and testing the metabolites generated by two psychoactive gut bacteria to alter brain function and behavior

Carlos Vidal Ribeiro

Fundação Champalimaud, Lisboa

N/A

Neuroscience

A

463.694

HR17- 00595

Organismal role of the ER membrane complex: a conserved machinery required for membrane protein biogenesis.

Colin Adrain

Calouste Gulbenkian Foundation, Lisboa

Institute of Chemical and Biological Technology (ITQB-NOVA, Lisboa), Institute of Organic Chemistry and Biochemistry of the CAS (Czech Republic)

Other biomedical areas

B

960.769

HR17- 00627

Dissecting the functional role of the epicardium metabolism during heart development and repair after myocardial infarction

Ofelia María Martínez Estrada

Fundació Bosch i Gimpera (UB)

Fundació Hospital Universitari Vall d'Hebron Institut de Recerca (VHIR), Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP)

Cardiovascular disease

A

438.100

Projetos premiados em colaboração com a Fundação Luzon

HR17- 00777

Activation of the resolution programs of inflammation as a novel therapeutic approach for the treatment of amyotrophic lateral sclerosis

Rubèn López Vales

Universitat Autònoma de Barcelona (UAB)

N/A

Neuroscience

A

500.000

Projetos premiados em colaboração com a Fundação para a Ciência e a Tecnologia, I.P. no âmbito da "Iniciativa Ibérica de Investigação e Inovação Biomédica, i4b"

HR17- 00523

Adenosine A2A receptors as a new opportunity to manage and detail the neurobiology of emotional distress

Rodrigo A. Cunha

Centro de Neurociências e Biologia Celular (CNC), Coimbra

N/A

Neuroscience

A

333.516

HR17- 00634

A Transdisciplinary Approach to the Identification of Personalized Biomarkers and Therapeutic Targets for Chronic Pulmonary Aspergillosis

Agostinho Albérico Rodrigues de Carvalho

Universidade do Minho

Fundación Universitaria San Pablo (CEU), Foundation for Research and Technology-Hellas, Jena University Hospital and Radboudumc

Infectious disease

B

999.027

HR17- 00601

Exosomal fat-liver axis in nonalcoholic fatty liver disease: function and targeting

Rui Eduardo Mota Castro

Universidade de Lisboa

Instituto Biodonostia, École polytechnique fédérale de Lausanne (EPFL) and CIC bioGUNE

Other biomedical areas

A

500.000

HR17- 00636

Sequential Cardiac Resynchronization Therapy

Joaquim Adelino Correia Ferreira Leite Moreira

Universidade do Porto

N/A

Cardiovascular disease

A

369.248